Table 2 Baseline characteristics before and after propensity score matching
Characteristics | Before matching (n = 140) | After matching (n = 82) | ||||
|---|---|---|---|---|---|---|
IVTA group (n = 41) | Control group (n = 99) | P value | IVTA group (n = 41) | Control group (n = 41) | P value | |
Age, mean(SD), y | 42.17 (7.72) | 45.90 (10.90) | 0.048 | 42.17 (7.72) | 42.07 (8.27) | 0.956 |
Gender, n(%) | 0.888 | 1.00 | ||||
Male | 21 (51.22) | 52 (52.53) | 21 (51.22) | 21 (51.22) | ||
Female | 20 (48.78) | 47 (47.47) | 20 (48.78) | 20 (48.78) | ||
Location of uveitis, n(%) | 0.599 | 0.647 | ||||
Anterior | 25 (60.98) | 65 (65.66) | 25 (60.98) | 27 (65.85) | ||
Panuveitis | 16 (39.02) | 34 (34.34) | 16 (39.02) | 14 (34.15) | ||
Duration of active inflammation, mean(SD), m | 7.74 (2.72) | 6.77 (4.09) | 0.162 | 7.74 (2.72) | 6.99 (3.12) | 0.246 |
Quiescent time of ocular inflammation, mean(SD), m | 7.78 (2.28) | 9.35 (3.89) | 0.017 | 7.78 (2.28) | 7.39 (2.36) | 0.449 |
Cataract surgery, n(%) | 0.915 | 1.00 | ||||
Unilateral | 31 (75.60) | 74 (74.75) | 31 (75.61) | 31 (75.60) | ||
Bilateral | 10 (24.40) | 25 (25.25) | 10 (24.39) | 10 (24.40) | ||